Hal K Berman Selected Research

Hal K Berman Research Topics

15	Neoplasms (Cancer) 10/2023 - 11/2007
5	Breast Neoplasms (Breast Cancer) 01/2022 - 12/2011
3	Carcinogenesis 01/2021 - 03/2005
2	Melanoma (Melanoma, Malignant) 01/2023 - 12/2022
2	Noninfiltrating Intraductal Carcinoma (DCIS) 05/2010 - 11/2007
1	Leiomyosarcoma 10/2023
1	Disease Progression 10/2023
1	Skin Neoplasms (Skin Cancer) 12/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2022
1	Genomic Instability 01/2021
1	Carcinoma (Carcinomatosis) 07/2014
1	Hyperplasia 12/2011
1	Neoplastic Processes 03/2005

4	Biomarkers (Surrogate Marker)IBA 12/2022 - 11/2007
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 10/2016
2	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2021
2	LipidsIBA 01/2023 - 12/2022
2	pembrolizumabIBA 01/2022 - 01/2021
2	ParaffinIBA 10/2016 - 05/2010
2	AntioxidantsIBA 02/2015 - 07/2013
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2010 - 03/2005
1	durvalumabIBA 10/2023
1	cediranib (AZD2171)IBA 10/2023
1	olaparibIBA 10/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2023
1	Melanins (Melanin)IBA 12/2022
1	HydrogelsIBA 01/2022
1	Circulating Tumor DNAIBA 01/2021
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2021
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2021
1	Formaldehyde (Formol)FDA Link 10/2016
1	CarcinogensIBA 03/2015
1	Glutathione (Reduced Glutathione)IBA 02/2015
1	ThioredoxinsIBA 02/2015
1	AntibodiesIBA 02/2015
1	Cyclin D1IBA 07/2014
1	CyclinsIBA 07/2014
1	Messenger RNA (mRNA)IBA 06/2014
1	Proteins (Proteins, Gene)FDA Link 06/2014
1	Estrogens (Estrogen)FDA Link 07/2013
1	Small Interfering RNA (siRNA)IBA 01/2013
1	Jagged-1 ProteinIBA 01/2013
1	Phosphotransferases (Kinase)IBA 01/2013
1	LigandsIBA 01/2013
1	Cyclin-Dependent Kinase Inhibitor p16IBA 12/2011
1	Estrogen ReceptorsIBA 05/2010
1	Oncogene Proteins (Oncogene Protein)IBA 05/2010
1	Ki-67 Antigen (Ki 67 Antigen)IBA 05/2010
1	Progesterone Receptors (Progesterone Receptor)IBA 05/2010
1	Epidermal Growth Factor (EGF)IBA 05/2010

3	Lasers (Laser) 01/2023 - 11/2018
2	Segmental Mastectomy (Lumpectomy) 05/2010 - 11/2007
1	Immunotherapy 10/2023
1	Drug Therapy (Chemotherapy) 01/2021
1	Neoadjuvant Therapy 02/2019